FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

425646006: Tetracosactide acetate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2007. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2674735011 Cosyntropin acetate en Synonym Active Entire term case insensitive SNOMED CT core module
2674736012 Tetracosactide acetate en Synonym Active Entire term case insensitive SNOMED CT core module
3484967018 Tetracosactide acetate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tetracosactide acetate Is a Tetracosactide false Inferred relationship Existential restriction modifier
Tetracosactide acetate Has disposition Anterior pituitary hormone true Inferred relationship Existential restriction modifier
Tetracosactide acetate Is a Corticotropic agent false Inferred relationship Existential restriction modifier
Tetracosactide acetate Is modification of Tetracosactide true Inferred relationship Existential restriction modifier
Tetracosactide acetate Is a Synthetic hormone agent false Inferred relationship Existential restriction modifier
Tetracosactide acetate Is a Adrenocorticotropic hormone false Inferred relationship Existential restriction modifier
Tetracosactide acetate Is a Adrenocorticotropic hormone and/or adrenocorticotropic hormone derivative true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely tetracosactide acetate 250 microgram/1 milliliter conventional release solution for injection ampule Has precise active ingredient False Tetracosactide acetate Inferred relationship Existential restriction modifier 1
Product containing precisely tetracosactide acetate 250 microgram/1 milliliter conventional release solution for injection ampule Has basis of strength substance False Tetracosactide acetate Inferred relationship Existential restriction modifier 1
Product containing precisely tetracosactide acetate 250 microgram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Tetracosactide acetate Inferred relationship Existential restriction modifier 1
Product containing precisely tetracosactide acetate 250 microgram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Tetracosactide acetate Inferred relationship Existential restriction modifier 1
Product containing precisely tetracosactide (as tetracosactide acetate) 250 microgram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Tetracosactide acetate Inferred relationship Existential restriction modifier 1
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule Has specific active ingredient True Tetracosactide acetate Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Has specific active ingredient True Tetracosactide acetate Inferred relationship Existential restriction modifier
Tetracosactrin 250micrograms/1mL injection Has specific active ingredient False Tetracosactide acetate Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) 5 ampoule Has specific active ingredient True Tetracosactide acetate Inferred relationship Existential restriction modifier
Synacthen Depot 1mg/1ml suspension for injection ampoules (Atnahs Pharma UK Ltd) 10 ampoule Has specific active ingredient True Tetracosactide acetate Inferred relationship Existential restriction modifier
Tetracosactide 1mg/1ml suspension for injection ampoules 10 ampoule Has specific active ingredient True Tetracosactide acetate Inferred relationship Existential restriction modifier
Tetracosactide 1mg/1ml suspension for injection ampoules Has specific active ingredient True Tetracosactide acetate Inferred relationship Existential restriction modifier
Synacthen Depot 1mg/1ml suspension for injection ampoules (Atnahs Pharma UK Ltd) Has specific active ingredient True Tetracosactide acetate Inferred relationship Existential restriction modifier
Tetracosactide 1mg/1ml suspension for injection ampoules 1 ampoule Has specific active ingredient True Tetracosactide acetate Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 1 ampoule Has specific active ingredient True Tetracosactide acetate Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) 1 ampoule Has specific active ingredient True Tetracosactide acetate Inferred relationship Existential restriction modifier
Synacthen Depot 1mg/1ml suspension for injection ampoules (Atnahs Pharma UK Ltd) 1 ampoule Has specific active ingredient True Tetracosactide acetate Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules Has specific active ingredient False Tetracosactide acetate Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules Has specific active ingredient True Tetracosactide acetate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start